Antimicrobial and Antiherpetic Properties of Nanoencapsulated Hypericum perforatum Extract

被引:0
|
作者
Sotirova, Yoana [1 ]
Ivanova, Nadezhda [1 ]
Ermenlieva, Neli [2 ]
Vilhelmova-Ilieva, Neli [3 ]
Simeonova, Lora [3 ]
Metodiev, Miroslav [3 ]
Gugleva, Viliana [1 ]
Andonova, Velichka [1 ]
机构
[1] Med Univ Varna, Fac Pharm, Dept Pharmaceut Technol, Varna 9000, Bulgaria
[2] Med Univ Varna, Fac Med, Dept Microbiol & Virol, Varna 9000, Bulgaria
[3] Bulgarian Acad Sci, Stephan Angeloff Inst Microbiol, Dept Virol, 26 G Bonchev Str, Sofia 1113, Bulgaria
关键词
antibacterial activity; antifungal activity; antimicrobial activity; antiviral activity; herpesvirus; hyperforin; lipid nanoparticles; nanostructured lipid carriers; phloroglucinols; St. John's wort; ST-JOHNS-WORT; ANTIBACTERIAL ACTIVITY; ANTIBIOFILM ACTIVITY; HYPERFORIN; ANTIOXIDANT; IDENTIFICATION;
D O I
10.3390/ph18030366
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Background/Objectives: This study aims to gain insights into the antimicrobial and antiherpetic activity of hyperforin-rich Hypericum perforatum L. (HP) extract using nanostructured lipid carriers (NLCs) as delivery platforms. Methods: Two established NLC specimens, comprising glyceryl behenate and almond oil or borage oil, and their extract-loaded counterparts (HP-NLCs) were utilized. Their minimal bactericidal/fungicidal concentrations (MBC; MFC) were investigated against Escherichia coli ATCC 25922, Staphylococcus aureus ATCC 25923, Pseudomonas aeruginosa ATCC 10145, Klebsiella pneumoniae ATCC 10031, and Candida albicans ATCC 10231. The anti-herpesvirus (HSV-1) potential was evaluated concerning antiviral and virucidal activity and impact on viral adsorption. Results: The borage oil-based extract-loaded nanodispersion (HP-NLC2) exhibited pronounced microbicidal activity against S. aureus (MBC 6.3 mg/mL), K. pneumoniae (MBC 97.7 mu g/mL), and C. albicans (MFC < 48.8 <mu>g/mL), unlike the almond oil-containing sample (HP-NLC1), which showed only weak inhibition of the fungal growth. HP-NLC2 was found to be less cytotoxic and to suppress HSV-1 replication slightly more than HP-NLC1, but generally, the effects were weak. Neither the empty lipid nanoparticles nor the HP extract-loaded carriers expressed activity against E. coli, P. aeruginosa, the HSV-1 extracellular virions, or viral adhesion. Conclusions: It could be concluded that both HP-NLC samples revealed only minor antiherpetic potential of the hyperforin-rich extract, but HP-NLC2 demonstrated significant antibacterial and antimycotic activity. Therefore, the latter was featured as a more convenient HP-carrier system for nano-designed dermal pharmaceutical formulations. Such a thorough investigation of hyperforin-determined anti-HSV-1 effects and antibacterial and antimycotic properties, being the first of its kind, contributes to the fundamental knowledge of HP and reveals new perspectives for the utilization, limitations, and therapeutic designation of its non-polar components.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] Effects of Hypericum perforatum extract in a rat model of ischemia and reperfusion injury
    De Paola, R
    Muiá, C
    Mazzon, E
    Genovese, T
    Crisafulli, C
    Menegazzi, M
    Caputi, AP
    Suzuki, H
    Cuzzocrea, S
    SHOCK, 2005, 24 (03): : 255 - 263
  • [32] Photodynamic action of Hypericum perforatum hydrophilic extract against Staphylococcus aureus
    Pietro Delcanale
    Cormac Hally
    Santi Nonell
    Silvia Bonardi
    Cristiano Viappiani
    Stefania Abbruzzetti
    Photochemical & Photobiological Sciences, 2020, 19 : 324 - 331
  • [33] Sedative activity in mice of an hydroalcoholic extract of Hypericum perforatum L.
    Girzu, M
    Carnat, A
    Privat, AM
    Fialip, J
    Carnat, AP
    Lamaison, JL
    PHYTOTHERAPY RESEARCH, 1997, 11 (05) : 395 - 397
  • [34] Role of hyperforin in the antidepressant-like activity of Hypericum perforatum extract
    Cervo, L
    Rozio, M
    Soppo, CBE
    Riva, A
    Morazzoni, P
    Caccia, S
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S195 - S195
  • [35] OPTIMAL CONDITIONS FOR PURIFICATION AND DRYING OF DRY EXTRACT FROM THE AERIAL PART OF Hypericum scabrum AND Hypericum perforatum
    Abdurakhmanov, B. A.
    Ibragimov, T. F.
    Sotimov, G. B.
    Khalilov, R. M.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2023, 57 (05) : 669 - 674
  • [36] Optimal Conditions for Purification and Drying of Dry Extract from the Aerial Part of Hypericum scabrum and Hypericum perforatum
    B. A. Abdurakhmanov
    T. F. Ibragimov
    G. B. Sotimov
    R. M. Khalilov
    Pharmaceutical Chemistry Journal, 2023, 57 : 669 - 674
  • [37] Safety of Hypericum perforatum
    Firenzuoli, F
    Luigi, G
    JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 1999, 5 (05) : 397 - 398
  • [38] Toxicity of Hypericum perforatum
    Firenzuoli, F
    Gori, L
    FORSCHENDE KOMPLEMENTARMEDIZIN, 1999, 6 (05): : 271 - 271
  • [39] Effect of Hypericum perforatum Extract in an Experimental Model of Binge Eating in Female Rats
    Di Bonaventura, Maria VittoriaMicioni
    Vitale, Giovanni
    Massi, Maurizio
    Cifani, Carlo
    JOURNAL OF OBESITY, 2012, 2012
  • [40] Effects of the total extract and fractions of hypericum perforatum in animal assays for antidepressant activity
    Butterweck, V
    Wall, A
    LieflanderWulf, U
    Winterhoff, H
    Nahrstedt, A
    PHARMACOPSYCHIATRY, 1997, 30 : 117 - 124